Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to ...

Guidance for 2026 is for 5.4% midpoint revenue growth and 9% adjusted EPS growth, compared to 2025's 7% revenue and 13% EPS ...

Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or ...

Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, banking on robust demand ...

In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...

LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions ...